Dr Reddys Laboratories (RDY) Income from Continuing Operations (2009 - 2026)
Dr Reddys Laboratories' Income from Continuing Operations came in at $45.93 million for the quarter ended Jun 30, 2026, down 72.1% from $164.71 million a year earlier but up 90.4% from the prior quarter.
Dr Reddys Laboratories (RDY) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Dr Reddys Laboratories reported Income from Continuing Operations of $367.21 million, down 45.6% year-over-year; for the year ended Mar 31, 2026, it was $452 million, down 33.5% from the prior year.
- Income from Continuing Operations carries a five-year compound annual growth rate of 13.9% (years ended Mar 2021 to Mar 2026).
- Going back by year, Income from Continuing Operations was $679.6 million in the year ended Mar 31, 2025 (+1.7%), $668 million in the year ended Mar 31, 2024 (+21.9%), $548 million in the year ended Mar 31, 2023 (+76.2%) and $311 million in the year ended Mar 31, 2022 (+31.8%).
- The five-year range for quarterly Income from Continuing Operations is $11.64 million (the quarter ended Mar 31, 2022) to $183.3 million (the quarter ended Mar 31, 2025).
- Year-over-year, Income from Continuing Operations has declined for three consecutive quarters, with an average decline of 21.4% over the last eight quarters.
- The fastest year-over-year change in Income from Continuing Operations over five years came in the quarter ended Dec 31, 2022 (growth of 143.8%), and the weakest in the quarter ended Mar 31, 2026 (a decline of 86.8%).
- Business Quant data shows RDY's Income from Continuing Operations at $24.12 million (quarter ended Mar 31, 2026), $133.59 million (quarter ended Dec 31, 2025) and $163.58 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -246.00 Mn |
| 10 | Dr Reddys Laboratories | 10.97 Bn | 10.34 Bn | 396.53 Mn | 45.93 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 45.93 Mn |
| Mar 31, 2026 | 24.12 Mn |
| Dec 31, 2025 | 133.59 Mn |
| Sep 30, 2025 | 163.58 Mn |
| Jun 30, 2025 | 164.71 Mn |
| Mar 31, 2025 | 183.30 Mn |
| Dec 31, 2024 | 166.26 Mn |
| Sep 30, 2024 | 160.17 Mn |
| Jun 30, 2024 | 166.87 Mn |
| Mar 31, 2024 | 157.38 Mn |
| Dec 31, 2023 | 165.60 Mn |
| Sep 30, 2023 | 179.04 Mn |
| Jun 30, 2023 | 170.00 Mn |
| Mar 31, 2023 | 169.00 Mn |
| Dec 31, 2022 | 117.00 Mn |
| Sep 30, 2022 | 152.00 Mn |
| Jun 30, 2022 | 135.00 Mn |
| Mar 31, 2022 | 11.64 Mn |
| Dec 31, 2021 | 48.00 Mn |
| Sep 30, 2021 | 93.00 Mn |
Dr Reddys Laboratories Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();